We have previously demonstrated that IDO expression in tumor cell lines is under the control of cytokines produced by activated T lymphocytes and that IL-13 has the capacity to repress IFN-γ-dependent induction of IDO [4]. This evidence concerns the gene IDO1 and neoplasm.